![]() |
|
|||||||
![]() |
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
|
|||
|
|||
|
* says Axalimogene Filolisbac showed 38.5 percent 12-month survival in patients with persistent/recurrent metastatic cervical cancer ??????? ??????: BRIEF-Advaxis says therapy improves survival rates in cervical cancer patients || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|